Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.

about

Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.

Item

http://www.wikidata.org/entity/Q38874266

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antiretroviral treatment in HI ...... ning regimen for tuberculosis.

@en

type

Item

label

Antiretroviral treatment in HI ...... ning regimen for tuberculosis.

@en

prefLabel

Antiretroviral treatment in HI ...... ning regimen for tuberculosis.

@en

P1476

Antiretroviral treatment in HI ...... ning regimen for tuberculosis.

@en

P2093

Anneke Hesseling

http://www.w3.org/2001/XMLSchema#string

Anthony J Garcia-Prats

http://www.w3.org/2001/XMLSchema#string

Eric H Decloedt

http://www.w3.org/2001/XMLSchema#string

H Simon Schaaf

http://www.w3.org/2001/XMLSchema#string

Lisa Frigati

http://www.w3.org/2001/XMLSchema#string

Mark F Cotton

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

Modeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro data

Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs

Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia.

Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.

Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers.

Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.

P304

589-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1309023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Lallemant

Helena Rabie

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28346018

http://www.w3.org/2001/XMLSchema#string